<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_TU-Delft_PeptideCharacterization"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:TU-Delft/PeptideCharacterization">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:TU-Delft/PeptideCharacterization&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:TU-Delft/PeptideCharacterization&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:TU-Delft/PeptideCharacterization&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:TU-Delft/PeptideCharacterization" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:TU-Delft/PeptideCharacterization</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2013.igem.org</H3><UL id="menu"><LI><A href="https://2013.igem.org/Team:TU-Delft">Home</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Team">Team</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Project">Project</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/ProjectOverview">Overview</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Sensing">Sensing Device</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Peptides">Peptide Production</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/PeptideCharacterization">Peptide Characterization</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Timer">Timer</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Killswitch">Kill switch</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/FinalApplication">Band Aid Application</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/new_Standard">New Standard Approach</A></LI></UL><LI><A href="https://2013.igem.org/Team:TU-Delft/Achievements">Achievements</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Notebook">Notebook</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Planning">Planning</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Protocols">Protocols</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Parts">Parts</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Modeling">Modeling</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Timer_Plus_Sumo">Timer plus SUMO</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/KillSwitch">Kill Switch</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Timer-Sumo-KillSwitch">Timer-SUMO-Kill Switch</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/BandAid">Band Aid</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/NovelPeptides">Novel Peptides</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Safety">Safety</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/human practice">Human Practice</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/novel_approach">Novel Approach</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/BandAidSelection">BandAid</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Zephyr"> Zephyr  </A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Zephyr_How"> Zephyr: How? </A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/SynBioData">Wiki Interviews</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Meet_with_RIVM">Meeting with RIVM</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Summer Festival">Human Outreach</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Extras">Extras</A></LI><LI><A href="https://2013.igem.org/Http://2013.igem.org/Team:TU-Delft/Acknowledgements">Acknowledgements</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Collaborations">Collaborations</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/PR">PR</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/iGemNetherlandsCollaboration">iGEM Netherlands</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/MeetChristopherVoigt">Meet with Christopher Voigt</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Gallery">Photo Gallery</A></LI><LI><A href="https://2013.igem.org/Team:TU-Delft/Brainstorm">Brainstorm</A></LI><DIV style="margin-left:30px;margin-right:30px; width:900px;float:left;"><H2 align="center"><SPAN class="mw-headline" id="Peptide_Characterization">Peptide Characterization</SPAN></H2><P align="justify">
An important part of the project is inhibition of growth or killing of bacteria with the use of antimicrobial peptides (AMPs). In order to get an idea of the toxicity of our peptides we conducted several minimal inhibiting concentration (MIC) experiments. These MIC measurements where done on <I>E. coli</I>, <I>B. subtilis</I> and<I>S. delphini</I>, with the first as representative of our Gram-negative expression host, the second for the Gram-positive targets and the last for our specific target. The AMPs Signiferin, maximin H5 and magainin were chosen from literature <A href="https://2013.igem.org/Team:TU-Delft/PeptideCharacterization#references">[1,2,3]</A> as being active against staphylococcus species but not against E. coli in order to able to use the latter as the expression host. MICs were also determined for the novel peptides we designed as described (<A href="https://2013.igem.org/Team:TU-Delft/NovelPeptides" target="blank"> here</A>).  
</P><H4 align="left">Procedure</H4><OL><LI>Grow the appropriate strains overnight and make a 1/50 to 1/100 dilution the next morning and wait for the OD at 600nm to reach 0,4-0,6.</LI><LI>Make a 100µM stock of the AMP in LB medium, this solution will serve as a 100 X stock, as the expected MIC range of our AMPs lays between 5 and 40 µM.</LI><LI>Then make the combinations as shown in table 1 in a 96 well plate, for the plate reader to take readings using an plate reader capable of shaking and heating to 37˚C. Taking measurements every 10 minutes.</LI></OL><DIV class="CSSTableGenerator"><TABLE><TBODY><TR><TD>
                         No cells + 1mM
                        </TD><TD>40µM</TD><TD>30µM</TD><TD>25µM</TD><TD>20µM</TD><TD>15µM</TD><TD>10µM</TD><TD>
                             7.5µM
                        </TD><TD>
                          5.0µM
                        </TD><TD>
                          2.0µM
                        </TD><TD>
                          1.0µM
                        </TD><TD>
                          Cell + No AMP
                        </TD></TR><TR><TD>
                         LB(µL)
                        </TD><TD>
                           90
                        </TD><TD>
                            55
                        </TD><TD>65</TD><TD>70</TD><TD>91</TD><TD>75</TD><TD>80</TD><TD>85</TD><TD>87.5</TD><TD>90</TD><TD>93</TD><TD>94</TD></TR><TR><TD>
                         Cells(µL)
                        </TD><TD>-</TD><TD>5</TD><TD>5</TD><TD>5</TD><TD>5</TD><TD>5</TD><TD>5</TD><TD>5</TD><TD>5</TD><TD>5</TD><TD>5</TD><TD>5</TD></TR><TR><TD>
                        100μΜ(µL)
                        </TD><TD>10</TD><TD>40</TD><TD>30</TD><TD>25</TD><TD>20</TD><TD>15</TD><TD>10</TD><TD>7.5</TD><TD>5.0</TD><TD>2.0</TD><TD>1.0</TD><TD>-</TD></TR></TBODY></TABLE></DIV><H2 align="center">Results</H2><H4 align="left">MIC determination</H4><P align="justify">
The MIC of signiferin on <I>S. delphini</I>, <I>B. subtilis</I> and <I>E. coli</I> were done according to the protocol described above. S. delphini is the most sensitive for signiferin, as the MIC was determined to be 1µM (Figure 1A), no growth is seen at this concentration. The MIC for B. subtilis was determined to be 10µM (Figure 1B). </P><CENTER><P>Figure 1: MICs of signiferin. 1A: signiferin on <I>S. delphini</I>, 1B: signiferin on <I>B. subtilus</I></P></CENTER></DIV><DIV style="margin-left:30px;margin-right:30px; width:900px;float:left;"><P align="justify">
The expected selectivity of the chosen peptides for Staphylococcus was confirmed by these experiments, as for all the peptides for which we could determine a MIC, that MIC was the lowest on <I>S. delphini.</I> Maximin H5 and magainin did not give a measurable reduction in growth below 40µM (Figure 2), making us decide not to proceed testing, as  <A href="https://2013.igem.org/Team:TU-Delft/Timer-Sumo-KillSwitch" target="blank">modeling</A> showed it was not possible to reach these concentrations through expression in <I>E.coli</I>.
</P><CENTER><P>Figure 2: MICs of maximin-H5 and magainin. 2A: maximin-H5 on <I>S. delphini</I>, 2B: magainin on <I>S.delphini</I></P></CENTER></DIV><DIV style="margin-left:30px;margin-right:30px; width:900px;float:left;"><P align="justify">
The fact that for none of the peptides a MIC could be determined for <I>E. coli</I> (&gt;150µM) further confirms the expected selectivity towards Gram-positives (Figure 3).</P><CENTER><P>Figure 3: MICs of Maximin-H5, Signiferin and Magainin on <I>E. coli</I></P></CENTER></DIV><DIV style="margin-left:30px;margin-right:30px; width:900px;float:left;">   
The modelers of the team designed novel peptides as described <A href="https://2013.igem.org/Team:TU-Delft/NovelPeptides" target="blank">here</A> and were named staphycine, peptidor and derpini. Two of these three peptides showed to be active against <I>S.delphini</I>; staphycine and peptidor, with MICs of respectively 30 and 40µM (Figure 4 and Figure 5). The MIC of staphycine on <I>B. subtilis</I> however was determined to be &lt;10µM (Figure 5B) lower than that for S. delphini. As for the peptides described above, no MIC could be determined for <I>E.coli</I> (Figure 6).
</DIV><CENTER><P>Figure 4: MICs of peptidor. 4A: peptidor on <I>S. delphini</I>, 4B: peptidor on <I>B. subtilus</I></P></CENTER><CENTER><P>Figure 5:MICs of staphycine 5A:staphycine on <I>S. delphini</I>, 5B: staphycine on <I>B. subtilus</I></P></CENTER><CENTER><P>Figure 6: MICs of peptidor  and staphycin. 6A peptidor on <I>E. coli</I>, 6B staphycine on <I>E. coli</I></P></CENTER><DIV style="margin-left:30px;margin-right:30px; width:900px;float:left;"><H4 align="left">COS-1 toxicity determination </H4><P align="justify">

In order to determine the toxicity of the AMPs on mammalian cells we tested the most promising peptides on COS-1 cells. COS-1 cells were chosen as they, because of their simian nature, strongly resemble human cells with respect to membrane properties and crucial cell functions and mechanisms <A href="https://2013.igem.org/Team:TU-Delft/PeptideCharacterization#references">[4]</A>. COS-1 cells are originally derived from Green African Monkey kidney cells in 1964, and since then have been extensively used in laboratoria around the world in molecular and cellular research on mammalian cells <A href="https://2013.igem.org/Team:TU-Delft/PeptideCharacterization#references">[5]</A>. As signifirin, staphycine and peptidor gave the best results in the experiments described above they were chosen to be tested with concentrations up to 150µM on COS-1 cells.  Normally healthy COS-1 cells attach to the bottom of the well, showing a clear fibroblastic morphology <A href="https://2013.igem.org/Team:TU-Delft/PeptideCharacterization#references">[6]</A>. When they start to die they will swell and eventually detach from the bottom forming spherical cells which upon lysis leave behind cell debris.    
</P><P align="justify">
Signifirin showed to be toxic above 100µM, whereas staphycine and peptidor turned out not to be toxic up to concentrations of 150µM (Figure 7). Two controls are shown, as peptidor and signiferin are dissolved in water whereas staphycine is in 80% DMSO. All photos shown are taken 24 hours after induction, but are representative for the photos taken 4 hours after induction. In the 150µM signiferin experiment no live cells could be observed at both 4 hours and 24 hours after induction.  
</P><CENTER><P>Figure 7: Toxicity test of AMPs on COS-1 cells </P></CENTER><H4 align="left">Discussion</H4><P align="justify">
The MIC experiments show three peptides to be effective against <I>S. delphini</I>, while not being toxic for E.coli or COS-1 cells. Two of the three peptides found are novel peptides designed by our modeler team. These peptides could be used in further research towards novel AMPs, as they also show a lower toxicity towards mammalian cells than the signiferin that was found in literature. Interesting to see is also that a low (&lt;10µM) was found for staphycine on <I>B. subtilis</I>, showing a low toxicity on mammalian cells does not necessarily mean lowering toxicity to bacterial species, what could be thought after comparing the MIC results with the toxicity tests on COS-1. We were not able to determine a MIC value for maximin, magainin and derpini, this could be due to multiple reasons. As derpini is a novel peptide, it could be assumed it is not designed properly and it is not toxic to one of the bacterial species tested on. Another reason, which would also go up for maximin and magainin, would be the possibility of cohesion of the peptides to the plastic tubes they were dissolved and kept in. A way to determine this could be to add a certain amount, 20-80% for example, of DMSO to the peptide solution. This could help the peptide to dissolve if cohesion to the plastic is the problem. The amount of DMSO would have to be adjusted for, but this should be no problem as this was also done for staphycine. 

</P><H2 align="center">References</H2><OL><LI> V.M. Maselli, D. Bilusich, et al., Host-defence skin peptides of the Australian Streambank Froglet <I>Crinia riparia</I>: isolation and sequence determination by positive and negative ion electrospray mass spectrometry, Rapid Communications in Mass Spectrometry, Volume 20, Issue 5, pages 797–803, Mar 2006.</LI><LI> Lai R, Liu H, et al., An anionic antimicrobial peptide from toad Bombina maxima, Biochem Biophys Res Commun, 26;295(4):796-9, Jul 2002</LI><LI> M. Zasloff, Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor, Proc Natl Acad Sci U S A.;84(15):5449-53 Aug 1987.
</LI><LI> Fred C. Jensen, Anthony J. Girardi, et al., “Infection of Human and Simian Tissue Cultures with Rous Sarcoma Virus”, Proc Natl Acad Sci U S A. 1964 July; 52(1): 53–59. Jul 1964.</LI><LI> J.F. Hancock, “COS Cell Expression”, Methods in Molecular Biology. Vol 8 pp 153-158, 1992.</LI><LI> P. Shashidharan,  G.W. Huntley, et al., “Immunohistochemical localization of the neuron-specific glutamate transporter EAAC1 (EAAT3) in rat brain and spinal cord revealed by a novel monoclonal antibody, Brain Research. Volume 773, Issues 1–2, Pages 139–148, Okt 1997.</LI></OL></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2013.igem.org/Team:TU-Delft/PeptideCharacterization">http://2013.igem.org/Team:TU-Delft/PeptideCharacterization</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:TU-Delft/PeptideCharacterization" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:TU-Delft/PeptideCharacterization" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:TU-Delft/PeptideCharacterization&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:TU-Delft/PeptideCharacterization&amp;oldid=296901" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2013.igem.org:Privacy_policy" title="2013.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2013.igem.org:General_disclaimer" title="2013.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>